000 | 01993 a2200589 4500 | ||
---|---|---|---|
005 | 20250517131935.0 | ||
264 | 0 | _c20170815 | |
008 | 201708s 0 0 eng d | ||
022 | _a1473-5598 | ||
024 | 7 |
_a10.1097/HJH.0000000000001213 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKoch, Sheryl E | |
245 | 0 | 0 |
_aTransient receptor potential vanilloid 2 function regulates cardiac hypertrophy via stretch-induced activation. _h[electronic resource] |
260 |
_bJournal of hypertension _c03 2017 |
||
300 |
_a602-611 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdrenergic beta-Agonists _xpharmacology |
650 | 0 | 4 |
_aAngiotensin II _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta _xpathology |
650 | 0 | 4 |
_aCalcium Channels _xgenetics |
650 | 0 | 4 |
_aConstriction, Pathologic _xcomplications |
650 | 0 | 4 | _aEchocardiography |
650 | 0 | 4 |
_aHeart _xphysiopathology |
650 | 0 | 4 |
_aHeart Failure _xphysiopathology |
650 | 0 | 4 |
_aHypertension _xphysiopathology |
650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xetiology |
650 | 0 | 4 |
_aIsoproterenol _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aMyocytes, Cardiac _xmetabolism |
650 | 0 | 4 |
_aSarcolemma _xmetabolism |
650 | 0 | 4 |
_aTRPV Cation Channels _xgenetics |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
700 | 1 | _aMann, Adrien | |
700 | 1 | _aJones, Shannon | |
700 | 1 | _aRobbins, Nathan | |
700 | 1 | _aAlkhattabi, Abdullah | |
700 | 1 | _aWorley, Mariah C | |
700 | 1 | _aGao, Xu | |
700 | 1 | _aLasko-Roiniotis, Valerie M | |
700 | 1 | _aKarani, Rajiv | |
700 | 1 | _aFulford, Logan | |
700 | 1 | _aJiang, Min | |
700 | 1 | _aNieman, Michelle | |
700 | 1 | _aLorenz, John N | |
700 | 1 | _aRubinstein, Jack | |
773 | 0 |
_tJournal of hypertension _gvol. 35 _gno. 3 _gp. 602-611 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/HJH.0000000000001213 _zAvailable from publisher's website |
999 |
_c26726766 _d26726766 |